Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 1/2 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Pain 9Cancer Pain 5Head and Neck Neoplasms 3Colonic Neoplasms 3Agnosia 3Rectal Neoplasms 2Chronic Pain 2Breakthrough Pain 2post laminectomy syndrome 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Terminal Cancer 1Prostatic Neoplasms 1Postoperative Cognitive Complications 1Polyps 1Pleural Effusion, Malignant 1Patient Satisfaction 1Pain, Postoperative 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Ileus 1Failed Back Surgery Syndrome 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Arrhythmias, Cardiac 1

Interventions

Morphine 3Fentanyl 2morphine, naltrexone combination 1Oxycodone 1Naltrexone 1Methadone 1Dexmedetomidine 1Buprenorphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Chronic Pain × Fentanyl × Clear all
NCT01902524 2014-08-28

Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain

Janssen Korea, Ltd., Korea

Phase 4 Completed
65 enrolled

Chronic Pain

NCT00916890 2014-01-09

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 4 Suspended
320 enrolled

Cancer Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡